Vnitr Lek 2009, 55(3):290-294

Laboratory procedures following thrombocytopenia diagnosis

L. Šáchová*, A. Urgasová, J. Gumulec
Hemato-onkologické a transfuzní centrum FN Ostrava, přednosta prim. MUDr. Jaromír Gumulec

Thrombocytopenia - decrease in the blood platelets count below 100 × 109/L - may represent a significant clinical complication - bleeding. A risk of haemorrhagic complications increases with the severity of thrombocytopenia. Even severe thrombocytopenia, however, may be a sign of a condition with predominant symptoms of thrombosis where bleeding is on the background (thrombotic microangiopathy, for example) or where bleeding occurs concurrently with symptoms of thrombosis (so called thrombohaemorrhagic syndromes). It is necessary to exclude pseudothrombocytopenia when thrombocytopenia is first diagnosed. It is then recommended to follow a standardized differential diagnosis algorithm that should be available at each clinical site. We summarize the general rules of thrombocytopenia differential diagnosis with a specific focus on laboratory processes.

Keywords: thrombocytopenia; pseudothrombocytopenia; differential diagnosis

Received: January 30, 2009; Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šáchová L, Urgasová A, Gumulec J. Laboratory procedures following thrombocytopenia diagnosis. Vnitr Lek. 2009;55(3):290-294.
Download citation

References

  1. Elting LS, Rubenstein EB, Martin CG et al. Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia. J Clin Oncol 2001; 19: 1137-1146. Go to original source... Go to PubMed...
  2. Shanafelt TD, Fonseca R. Thrombocytopenia. In: Oliveira GHM, Nesbit GC, Murphy JG. Mayo Clinic Medical Manual. Mayo Clinic Scientific Press 2006. Go to original source...
  3. Guidelines on the Diagnosis and Management of the Thrombotic Microangiopathic Haemolytic Anaemias. Br J Haematol 2003; 120: 556-573. Go to original source... Go to PubMed...
  4. Warkentin T, Greinacher A, Lincoff AM et al. Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest 2008; 340S-380S. Go to original source...
  5. Payne BA, Pierre RV. Pseudotrombocytopenia: A laboratory artifact with potentially serious complications consequences. Mayo Clin Proc 1984; 59: 123-125. Go to original source... Go to PubMed...
  6. Berkman N, Michaeli Y, Or R et al. EDTA-dependent pseudothrombocytopenia: A clinical study of 18 patients and a review of the literature. Am J Hematol 1991; 36: 195-201. Go to original source... Go to PubMed...
  7. Schrezenmeier H, Müller H, Gunsilius E et al. Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis. Thromb Haemost 1995; 73: 506-513. Go to original source... Go to PubMed...
  8. Bizzaro N. Platelet satellitosis to polymorphonuclears: Cytochemical, imunological, and ultrastructural characterization of eight cases. Am J Hematol 1991; 36: 235-242. Go to original source... Go to PubMed...
  9. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Hematol 2003; 120: 556-557.
  10. Mayer SA, LM. Aledort Thrombotic Microangiopathy: Differential Diagnosis, Pathophysiology and Therapeutic Strategies. Mt Sinai J Med 2005; 72: 166-175.
  11. Nguyen TC, Carcillo JA. Bench-to-bedside review: Thrombocytopenia-associated multiple organ failure - a newly appreciated syndrome in the critically ill. Critical Care 2006; 10: 235-242. Go to original source... Go to PubMed...
  12. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Critical Care 2006; 10: 222-230. Go to original source... Go to PubMed...
  13. Espinosa G, Bucciarelli S, Cervera R et al. Thrombotic microangiopathic haemolytic anemia and antiphospholipid antibodies. Ann Rev Rheum Dis 2004; 63: 730-736. Go to original source... Go to PubMed...
  14. Taylor FBJ, Toh CH, Hoots WK et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-1330. Go to original source... Go to PubMed...
  15. Krejčí M, Šmardová J, Adam Z. Akutní myeloidní leukemia. In: Adam Z, Krejčí M, Vorlíčk J et al. Hematologie, přehled maligních hematologických onemocnění. 2. dopl. a zcela přepr. vyd. Praha: Grada Publishing 2008; 29-38.
  16. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2005; 4: 295-306. Go to original source... Go to PubMed...
  17. Nové informace OLM MOU. Dostupnost na www.mou.cz/section.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.